CNBC Daily Open: The U.S. economy gives conflicting signals

CNBC Daily Open: The U.S. economy gives conflicting signals


Traders work on the floor of the New York Stock Exchange (NYSE) on July 25, 2022 in New York City.

Spencer Platt | Getty Images News | Getty Images

This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? You can subscribe here.

U.S. stocks drop as the Treasury yields widen their inversion. The U.S. economy gives conflicting signals.

What you need to know today

  • U.S. stocks closed lower Thursday, giving up a midday rally. The Nasdaq saw the biggest loss of the major indexes, dropping 1.02%. Asia-Pacific largely fell on Wednesday, though Chinese markets beat the trend and rose.
  • Speaking of activists, Dan Loeb’s hedge fund Third Point is the latest activist investor to take a stake in Salesforce, CNBC confirmed. It joins ValueAct Capital, Elliott Management and Starboard Value.  Salesforce has been hit recently by slowing revenue growth and criticism that it paid too much for targets such as Slack.

The bottom line

The January rally seems to be fizzling as investors process the strange state of the U.S. economy.

Weekly jobless claims in the U.S. hit 196,000 for the week ending Feb. 4. Though it’s an increase of 13,000 from the prior week, it’s still one of the lowest numbers historically. Yet the number is more than what analysts expected and runs contrary to January’s jobs data, which reported record low unemployment.

Despite a strong labor market, the Treasury yield curve remains inverted — meaning the yield on the 2-year Treasury exceeds that of the 10-year Treasury. On Thursday, the inversion widened. That usually indicates investors are worried about market conditions in the near term, and it sometimes signals a recession.

Those economic signals, in combination with the Federal Reserve’s continuing, hawkish tones, seemed to give investors pause. On Thursday, U.S. stocks continued their two-day losing streak. The Dow Jones Industrial Average lost 0.73% and the S&P 500 fell 0.9%. The tech-heavy Nasdaq Composite, weighed down by a 4% slide in Google-parent Alphabet and a 3% decline in Meta, dropped 1.02%.

Until economic data paints a more coherent picture of the U.S. economy, it’s likely that markets stay choppy.

Subscribe here to get this report sent directly to your inbox each morning before markets open.



Source

E.l.f. Beauty posts earnings beat, raises full-year guidance
Business

E.l.f. Beauty posts earnings beat, raises full-year guidance

Elf Beauty cosmetics Courtesy: e.l.f Beauty E.l.f. Beauty reported a huge earnings beat Wednesday and raised its guidance for the fiscal year. E.l.f. stock was up as much as 15% in after-hours trading before losing the majority of those gains. Here’s what the company reported for the third fiscal quarter, compared with analyst estimates from […]

Read More
Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs
Business

Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs

NFL Hall of Famer Terrell Owens said Wednesday that the recent snubs of New England Patriots owner Robert Kraft and former coach Bill Belichick from the institution show the system is flawed, and someone needs to be held accountable. “It’s just plain dumb” Owens told CNBC Sport in an interview in San Francisco ahead of […]

Read More
Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Business

Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market.  Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S., but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline, […]

Read More